SQSTM1 and prostate carcinoma: An in vivo study by Huang et al. has proposed that the selective inactivation of p62/SQSTM1 in adipocytes increases osteopontin levels, boosting fatty-acid oxidation in cancer cells and eventually leading to the development of invasive metastatic prostate cancers [68].